Matt Price drove his 73-year-old father Stephen from their New Jersey home to a medical strip mall on the Jersey Shore, for his first injection of an experimental drug called ...
Few companies in the biotech industry have performed better in the past two years than Summit Therapeutics (NASDAQ: SMMT).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback